Tuesday, April 28, 2026

#biotech stocks

4 articles

Cardiff Oncology CEO Faces FDA Trial Endpoint Risk as Q1 Data Nears

Earnings & Corporate Events

Cardiff Oncology CEO Faces FDA Trial Endpoint Risk as Q1 Data Nears

ViaNews Editorial Team (Markets)•Mar 7, 2026

Biomerica Faces Going Concern Crisis as Operating Losses Drain Cash Reserves

Biomerica Faces Going Concern Crisis as Operating Losses Drain Cash Reserves

ViaNews Editorial Team (Markets)•Feb 21, 2026

Precision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory Milestones

Biotech & Pharma Stocks

Precision Oncology Stocks Poised for Catalyst-Rich Quarter as Multiple Biotech Firms Race Toward Regulatory Milestones

ViaNews Editorial Team (Markets)•Feb 15, 2026

ARK Invest Shifts Focus to Early-Stage Biotech, Reduces Tech Exposure

ARK Invest Shifts Focus to Early-Stage Biotech, Reduces Tech Exposure

ViaNews Editorial Team (Markets)•Jan 5, 2026